Nonspecific inhibition of nitric oxide synthesis evokes endothelin-dependent increases in myocardial contractility

Nitric Oxide - Biology and Chemistry

Volumn 21, Issue 3-4, 2009, Pages 201-209

  Czóbel, Miklós ^a   Kaszaki, József ^a   Molnár, Gábor ^a   Nagy, Sándor ^a   Boros, Mihály ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Endothelin 1; Endothelin A receptor; Myocardial contractility; Nitric oxide synthase; Superoxide; Xanthine oxidase

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; SUPEROXIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL DOG; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE BIOPSY; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOGS; ENDOTHELIN-1; ENZYME INHIBITORS; HEART; HEMODYNAMICS; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; XANTHINE DEHYDROGENASE;

CANIS FAMILIARIS;

EID: 71849094529     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.08.003     Document Type: Article

References (46)

1. Massion P.B., Feron O., Dessy C., and Balligand J.L. Nitric oxide and cardiac function: ten years after, and continuing. Circ. Res. 93 (2003) 388-398
2. Casadei B., and Sears C.E. Nitric-oxide-mediated regulation of cardiac contractility and stretch responses. Prog. Biophys. Mol. Biol. 82 (2003) 67-80
3. Paulus W.J., Vantrimpont P.J., and Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89 (1994) 2070-2078
4. Shetty S.S., Okada T., Webb R.L., DelGrande D., and Lappe R.W. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 191 (1993) 459-464
5. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., and Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90 (1993) 347-351
6. Keaney Jr. J.F., Hare J.M., Balligand J.L., Loscalzo J., Smith T.W., and Colucci W.S. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am. J. Physiol. 271 (1996) H2646-H2652
7. Cotton J.M., Kearney M.T., MacCarthy P.A., Grocott-Mason R.M., McClean D.R., Heymes C., Richardson P.J., and Shah A.M. Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation 104 (2001) 2318-2323
8. Han X., Shimoni Y., and Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol. 476 (1994) 309-314
9. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., Hobai I.A., Lemmon C.A., Burnett A.L., O'Rourke B., Rodriguez E.R., Huang P.L., Lima J.A., Berkowitz D.E., and Hare J.M. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 (2002) 337-339
10. Brady A.J., Warren J.B., Poole-Wilson P.A., Williams T.J., and Harding S.E. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265 (1993) H176-H182
11. Kojda G., Kottenberg K., Nix P., Schluter K.D., Piper H.M., and Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ. Res. 78 (1996) 91-101
12. Kilbourn R.G., Szabo C., and Traber D.L. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7 (1997) 235-246
13. Kaszaki J., Wolfard A., Bari F., Boros M., Parratt J.R., and Nagy S. Effect of nitric oxide synthase inhibition on myocardial contractility in anesthetized normal and endotoxemic dogs. Shock 6 (1996) 279-285
14. Kojda G., Kottenberg K., and Noack E. Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts. Eur. J. Pharmacol. 334 (1997) 181-190
15. Brunner F., Andrew P., Wolkart G., Zechner R., and Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104 (2001) 3097-3102
16. Gyurko R., Kuhlencordt P., Fishman M.C., and Huang P.L. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H971-H981
17. Godecke A., Heinicke T., Kamkin A., Kiseleva I., Strasser R.H., Decking U.K., Stumpe T., Isenberg G., and Schrader J. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J. Physiol. 532 (2001) 195-204
18. Boulanger C., and Luscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990) 587-590
19. Kourembanas S., McQuillan L.P., Leung G.K., and Faller D.V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92 (1993) 99-104
20. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
21. Filep J.G. Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension 30 (1997) 22-28
22. Richard V., Hogie M., Clozel M., Loffler B.M., and Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91 (1995) 771-775
23. Sumner M.J., Cannon T.R., Mundin J.W., White D.G., and Watts I.S. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107 (1992) 858-860
24. De Giusti V.C., Correa M.V., Villa-Abrille M.C., Beltrano C., Yeves A.M., de Cingolani G.E., Cingolani H.E., and Aiello E.A. The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sci. 83 (2008) 264-271
25. Channon K.M., and Guzik T.J. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J. Physiol. Pharmacol. 53 (2002) 515-524
26. Dixon L.J., Hughes S.M., Rooney K., Madden A., Devine A., Leahey W., Henry W., Johnston G.D., and McVeigh G.E. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Am. J. Hypertens. 18 (2005) 839-843
27. Khan S.A., Lee K., Minhas K.M., Gonzalez D.R., Raju S.V., Tejani A.D., Li D., Berkowitz D.E., and Hare J.M. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc. Natl. Acad. Sci. USA 101 (2004) 15944-15948
28. Kinugawa S., Huang H., Wang Z., Kaminski P.M., Wolin M.S., and Hintze T.H. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ. Res. 96 (2005) 355-362
29. Goldfarb R.D., Lee K.J., Andrejuk T., and Dziuban Jr. S.W. End-systolic elastance as an evaluation of myocardial function in shock. Circ. Shock 30 (1990) 15-26
30. Moshage H., Kok B., Huizenga J.R., and Jansen P.L. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41 (1995) 892-896
31. Zimmermann T., Schuster R., Lauschke G., and Trausch M. Chemiluminescence response of whole blood and separated blood cells in cases of experimentally induced pancreatitis and MDTQ-DA-Trasylol-ascorbic acid therapy. Anal. Chim. Acta 255 (1991) 373-381
32. Beckman J.S., Parks D.A., Pearson J.D., Marshall P.A., and Freeman B.A. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic. Biol. Med. 6 (1989) 607-615
33. Baranyi L., Campbell W., Ohshima K., Fujimoto S., Boros M., Kaszaki J., and Okada H. Antisense homology box-derived peptides represent a new class of endothelin receptor inhibitors. Peptides 19 (1998) 211-223
34. Baranyi L., Campbell W., Ohshima K., Fujimoto S., Boros M., and Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat. Med. 1 (1995) 894-901
35. Prendergast B.D., Sagach V.F., and Shah A.M. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96 (1997) 1320-1329
36. Gonzalez D.R., Fernandez I.C., Ordenes P.P., Treuer A.V., Eller G., and Boric M.P. Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide 18 (2008) 157-167
37. Banting J.D., Friberg P., and Adams M.A. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens. 14 (1996) 975-981
38. Kinnunen P., Szokodi I., Nicholls M.G., and Ruskoaho H. Impact of NO on ET-1- and AM-induced inotropic responses: potentiation by combined administration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R569-R575
39. Konrad D., Oldner A., Wanecek M., Rudehill A., Weitzberg E., Biber B., Johansson G., Haggmark S., and Haney M. Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1702-H1709
40. Robu V.G., Pfeiffer E.S., Robia S.L., Balijepalli R.C., Pi Y., Kamp T.J., and Walker J.W. Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules. J. Biol. Chem. 278 (2003) 48154-48161
41. Maeda S., Miyauchi T., Iemitsu M., Tanabe T., Goto K., Yamaguchi I., and Matsuda M. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E609-E614
42. Verhaar M.C., Strachan F.E., Newby D.E., Cruden N.L., Koomans H.A., Rabelink T.J., and Webb D.J. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97 (1998) 752-756
43. Kaszaki J., Wolfárd A., Boros M., Baranyi L., Okada H., and Nagy S. Effects of antiendothelin treatment on the early hemodynamic changes in hyperdynamic endotoxemia. Acta Chir. Hung. 36 (1997) 152-153
44. Hassoun P.M., Yu F.S., Zulueta J.J., White A.C., and Lanzillo J.J. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am. J. Physiol. 268 (1995) L809-L817
45. Caldiz C.I., Garciarena C.D., Dulce R.A., Novaretto L.P., Yeves A.M., Ennis I.L., Cingolani H.E., Chiappe de Cingolani G., and Pérez N.G. Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. J. Physiol. 584 (2007) 895-905
46. Zeng Q., Zhou Q., Yao F., O'Rourke S.T., and Sun C. Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide. J. Pharmacol. Exp. Ther. 326 (2008) 732-738